BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 11, 2013
View Archived Issues
Novel NOTCH3 gene mutation linked to CADASIL
Read More
Biomarkers identified for 90-day mortality after intracerebral hemorrhage
Read More
Blood pressure-lowering activity demonstrated for ARA-290
Read More
LGX-818 shows initial promise in solid tumors and melanoma
Read More
Zebrafish model/computational screening to accelerate drug discovery
Read More
The discovery of a first-in-class inhibitor of a major human oxidative stress pathway
Read More
PBI-4050 demonstrates promising antifibrotic properties in vivo
Read More
Genotype determines response to butyrate in patients with congenital chloride diarrhea
Read More
TissueGene-C therapy evaluated in patients with knee osteoarthritis
Read More
AVEO Oncology receives complete response letter for tivozanib NDA
Read More
BioLineRx enters collaboration with Jiangsu Chia-tai Tianqing Pharmaceutical
Read More
Concert Pharmaceuticals begins phase I trial of CTP-354
Read More
Discovery Labs responds to FDA request for clarification regarding Surfaxin specifications
Read More
Dynavax reports on FDA meeting for Heplisav
Read More
HemaQuest Pharmaceuticals completes enrollment in phase IIb HQK-1001 study
Read More
Neumedicines receives BARDA award for HemaMax
Read More
Centaurus BioPharma presents novel B-raf inhibitors
Read More
Trigemina begins phase II trial of TI-001 in chronic migraine
Read More
Seattle Genetics begins phase I/II trial of Adcetris in combination with bendamustine
Read More
Xenon Pharmaceuticals licenses XEN-701 from Isis Pharmaceuticals
Read More
Chinese team patents new EGFR inhibitors for cancer
Read More
Heptares Therapeutics designs novel M1 receptor agonists
Read More
New agents for the treatment of Coxsackie viral infections disclosed by Chinese group
Read More
KBP BioSciences presents new DP2 receptor antagonists
Read More
Global alliance initiated to share genomic and clinical data
Read More